EDGAR Filing Documents for 0001628280-19-014209

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001628280-19-014209

Filing Date

2019-11-14

Accepted

2019-11-14 16:05:24

Documents

Period of Report

2019-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	auph-0930196xk.htm	6-K	17961
2	EXHIBIT 99.1	exhibit991-20190930interim.htm	EX-99.1	725275
3	EXHIBIT 99.2	exhibit992-20190930mda.htm	EX-99.2	375603
4	EXHIBIT 99.3	exhibit993-20190930certifi.htm	EX-99.3	16005
5	EXHIBIT 99.4	exhibit994-20190930certifi.htm	EX-99.4	15752
6		aurinialogoweb700pxa07.jpg	GRAPHIC	77311
7		auroralogoa02.jpg	GRAPHIC	12814
8		consolidatedfinancialstate03.jpg	GRAPHIC	233177
9		consolidatedfinancialstate04.jpg	GRAPHIC	233177
	Complete submission text file	0001628280-19-014209.txt		1907353

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8

Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272

Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)